Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DREAM trial of duloxetine for chronic sciatica
ACTRN12624000919516Phase 4Recruiting
- Sponsor
- The University of Sydney
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Sciatica comparing Duloxetine in addition to usual care with Placebo in addition to usual care (2 arms). Primary endpoint: Leg pain intensity at 52 weeks. Started Feb 2025; status: recruiting.
02
Drugs
duloxetine
03
Conditions
Sciatica
Beyond the preview
Go deeper on ACTRN12624000919516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000919516.